<DOC>
	<DOCNO>NCT01981330</DOCNO>
	<brief_summary>This pilot-study 25 select Swedish patient severe hoarseness aphonia due vocal fold scarring ( previous surgery , radiation therapy , inflammation possibly hereditary ) . The patient operate phonomicrosurgical dissection scar vocal fold , removal scar tissue injection autologous mesenchymal stroma cell , aMSC ( previously harvest patientsÂ´s bone marrow , purify , expand characterize accord standard procedure Center Hematology Regenerative Medicine Karolinska University Hospital Huddinge ) . 14 Patients plan treated single injection aMSC 11 patient injection aMSC mixed carrier hyaluronan gel develop Uppsala University Sweden Karolinska Institute . The laryngeal status , vocal fold function , voice function follow individually advanced battery examination perform 1 year postoperatively . Side effect complication note report surgery follow surgery regular interval least 1 year Since autumn 2015 new patient recruited treatment give 2016 . The monitoring authority change Swedish National Board Health Swedish Medical Product Agency ( MPA ) March/April 2016 . Further inclusion treatment postpone permission grant MPA continue study .</brief_summary>
	<brief_title>Pilot Study Stem Cell Treatment Patients With Vocal Fold Scarring</brief_title>
	<detailed_description />
	<mesh_term>Cicatrix</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>severe hoarseness vocal fold scar active treatment age 18 year active treatment laryngeal disorder active inflammatory condition larynx diagnose suspicion local malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>vocal fold scarring</keyword>
	<keyword>mesenchymal stem cell</keyword>
</DOC>